Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

Cash In as This Rural Telephone Company Outsmarts the Sector Giants

As the longtime subscribers among you folks know, we love spin-offs here at Private Briefing.

These corporate breakups are a way to make market-beating returns – and at below-market risk.

It’s that penchant for spin-offs that prompted our pre-breakup recommendation of Abbott Laboratories Inc. (NYSE: ABT) back in June 2012.

  • JPMorgan (NYSE: JPM) Earnings Preview: Five Things to Watch The JPMorgan Chase (NYSE: JPM) earnings report due tomorrow (Friday) gives CEO Jamie Dimon a chance to put the huge trading losses from the "London Whale" behind him.

    The "London Whale" trades are the are hedged strategy that went bad and cost the bank nearly $6 billion. JPM took the majority of the hit in the second quarter.

    JPM stock tumbled in the weeks that followed after details were uncovered and trading losses swelled. Since then, shares have staged a notable recovery rising from $34.59 on July 11 to the recent price of $42.25.

    Now JPM earnings have a chance to shake off the scandal and impress investors.

    Expectations have grown for Friday's numbers, with the consensus estimate raised from $1.16 per share to projections of $1.21 per share. Estimates have increased in the last three months from $1.04.

    Analysts are predicting earnings of $4.74 per share for the fiscal year, with revenue for the year to come in at $97.76 billion.

    The fresh forecasts are 18.6% better from the same quarter a year ago when JPM posted earnings of $1.02 per share.

    To continue reading, please click here...
    Read More...